IMRX vs. ARKF
IMRX (Immuneering Corporation) is a stock, while ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK. Over the past 3 years, IMRX returned -19.52%/yr vs 20.97%/yr for ARKF. At a 0.27 correlation, their price movements are largely independent.
Performance
IMRX vs. ARKF - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IMRX achieves a -21.58% return, which is significantly lower than ARKF's -13.25% return.
IMRX
- 1D
- 0.98%
- 1M
- 23.15%
- 6M
- 22.27%
- YTD
- -21.58%
- 1Y
- 16.74%
- 3Y*
- -19.52%
- 5Y*
- —
- 10Y*
- —
ARKF
- 1D
- -0.74%
- 1M
- 6.19%
- 6M
- -16.15%
- YTD
- -13.25%
- 1Y
- -18.91%
- 3Y*
- 20.97%
- 5Y*
- -4.30%
- 10Y*
- —
IMRX vs. ARKF - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IMRX Immuneering Corporation | -21.58% | 199.09% | -70.07% | 51.55% | -70.01% | -17.08% |
ARKF ARK Fintech Innovation ETF | -13.25% | 28.67% | 34.34% | 93.27% | -65.07% | -21.35% |
Correlation
The correlation between IMRX and ARKF is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021 | 0.27 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMRX vs. ARKF — Risk / Return Rank
IMRX
ARKF
IMRX vs. ARKF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Immuneering Corporation (IMRX) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IMRX | ARKF | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.73 | ||
| Sortino ratioReturn per unit of downside risk | +1.63 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.93 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 0.29 | -0.49 | +0.78 |
| Martin ratioReturn relative to average drawdown | 0.46 | -0.83 | +1.29 |
Loading charts...
Drawdowns
IMRX vs. ARKF - Drawdown Comparison
The maximum IMRX drawdown since its inception was -96.86%, which is greater than ARKF's maximum drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for IMRX and ARKF.
Loading charts...
Drawdown Indicators
| IMRX | ARKF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.86% | -78.63% | -18.23% |
Max Drawdown (1Y)Largest decline over 1 year | -57.67% | -38.50% | -19.17% |
Max Drawdown (3Y)Largest decline over 3 years | -90.36% | -38.50% | -51.86% |
Max Drawdown (5Y)Largest decline over 5 years | — | -75.30% | — |
Current DrawdownCurrent decline from peak | -84.29% | -34.97% | -49.32% |
Average DrawdownAverage peak-to-trough decline | -77.73% | -34.97% | -42.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.93% | 22.71% | +14.22% |
Volatility
IMRX vs. ARKF - Volatility Comparison
Immuneering Corporation (IMRX) has a higher volatility of 15.52% compared to ARK Fintech Innovation ETF (ARKF) at 8.81%. This indicates that IMRX's price experiences larger fluctuations and is considered to be riskier than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMRX | ARKF | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.52% | 8.81% | +6.71% |
Volatility (6M)Calculated over the trailing 6-month period | 51.05% | 25.64% | +25.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 103.30% | 33.71% | +69.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.79% | 42.98% | +70.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.79% | 39.68% | +74.11% |
Dividends
IMRX vs. ARKF - Dividend Comparison
IMRX has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.10% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
IMRX Immuneering Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IMRX and ARKF have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IMRX has higher volatility (15.52%) compared to ARKF (8.81%). In terms of maximum drawdown, IMRX dropped -96.86% vs ARKF's -78.63%.
IMRX currently has the higher Sharpe Ratio (0.16 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IMRX and ARKF
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer